Neonc Technologies Holdings, Inc. (NTHI)
NASDAQ
Healthcare
Biotechnology
$4.44
▲ +2.07%
Market Cap
$115.1M
Sector
Healthcare
Industry
Biotechnology
Beta
0.50
52-Wk Range
3.005-12.99
CEO
Amir Farrokh Heshmatpour
Country
US
Currency
USD
Neonc Technologies Holdings, Inc. operates in the Biotechnology industry of the Healthcare sector, headquartered in Calabasas, CA, US. The stock last traded at $4.44, up 2.07% on the session, giving a market capitalisation of $115.1M. On trailing twelve-month figures it carries a trailing P/E of -2.29, a net margin of 0.0%. Its beta of 0.50 implies it has historically moved less than the broad market.
Valuation & profitability (TTM)
P/E
-2.29
Price / Sales
0.00
Price / Book
-7.82
EV / EBITDA
-3.28
Gross margin
0.0%
Operating margin
0.0%
Net margin
0.0%
Return on equity
—
Debt / equity
-0.03
Current ratio
0.08
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
NASDAQ Global Select
Employees
5
IPO date
2025-03-26
Headquarters
Calabasas, CA, US
About Neonc Technologies Holdings, Inc.
NeOnc Technologies Holdings, Inc. is a clinical-stage biopharmaceutical company. It develops novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. The company was founded in 2008 and is headquartered in Calabasas, CA.
More research on NTHI
Open full interactive analysis & DCF →